Multiple Sclerosis
Literature Review
Blood test could predict future disability in MS
“This rising of NfL up to 2 years before signs of disability worsening represents the window when interventions may prevent worsening.”
Conference Coverage
Artificial intelligence presents opportunities, challenges in neurologic practice
Programs can generate health care and research content, but require close supervision and an attitude of ‘trust, but verify.’
Conference Coverage
Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there...
Conference Coverage
‘Frame running’ may help boost physical activity in MS
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...
Conference Coverage
MS, DMTs, and pregnancy: Beware of over-caution regarding treatment
Don’t be too quick to stop therapy or too slow to restart it, researcher tells ECTRIMS audience.
Conference Coverage
Wearable devices show promise in monitoring multiple sclerosis
Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”
Conference Coverage
NMO: Study says double diagnoses with MS are common
Nearly half of patients with coding for NMO were also listed as having MS – a very similar condition.
Conference Coverage
EBV and MS: Just how deep is the link?
Two MS researchers disagree over how tightly they’re connected, and one says “second hit” may be factor.
Conference Coverage
Stem cell transplants in early MS: Who benefits most?
Neurologists outline findings as the MS field works toward consensus on HSCT as rescue therapy.
Conference Coverage
MS-tailored weight loss program achieves meaningful results
Weight loss “was associated with improved mobility, reduced fatigability, and improved physical quality of life.”
Conference Coverage
‘We’re halfway home’: UCSF’s Dr. Stephen Hauser sketches MS future
Identification of a reliable MS biomarker as well as early detection and intervention will be key going forward.